Authors
Amiee Kang, MPH
Latest:
Journey to Anticoagulant Access Following Payer Rejection of ApixabanFormulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.
Jai Seth, MSc
Latest:
Leveraging Patient Activation to Improve Kidney Health in High-Risk PatientsFrequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease.
